Volume 16, Number 12—December 2010
Bartonella henselae in Skin Biopsy Specimens of Patients with Cat-Scratch Disease
Highlight and copy the desired format.
|EID||Angelakis E, Edouard S, La Scola B, Raoult D. Bartonella henselae in Skin Biopsy Specimens of Patients with Cat-Scratch Disease. Emerg Infect Dis. 2010;16(12):1963-1965. https://dx.doi.org/10.3201/eid1612.100647|
|AMA||Angelakis E, Edouard S, La Scola B, et al. Bartonella henselae in Skin Biopsy Specimens of Patients with Cat-Scratch Disease. Emerging Infectious Diseases. 2010;16(12):1963-1965. doi:10.3201/eid1612.100647.|
|APA||Angelakis, E., Edouard, S., La Scola, B., & Raoult, D. (2010). Bartonella henselae in Skin Biopsy Specimens of Patients with Cat-Scratch Disease. Emerging Infectious Diseases, 16(12), 1963-1965. https://dx.doi.org/10.3201/eid1612.100647.|
During the past 2 years, we identified live Bartonella henselae in the primary inoculation sites of 3 patients after a cat scratch. Although our data are preliminary, we report that a cutaneous swab of the skin lesion from a patient in the early stage of cat-scratch disease can be useful for diagnosis of the infection.
Bartonella henselae is the main causative agent of cat-scratch disease (CSD). Little is known about the organism’s pathogenesis in long-lasting lymphadenopathy, but an immunopathogenesis is assumed (1). B. henselae is infrequently grown from the lymph nodes of humans, and only in a few cases was B. henselae isolated from patients with CSD (2,3). In experiments with mice, B. henselae was eliminated within a few days to 1 week after systemic (intraperitoneal or intravenous) infection (4). Moreover, on the basis of molecular methods, we recently identified that the scalp eschars from 2 patients who were bitten by a tick contained B. henselae (5). In this study, our objective was to determine if B. henselae was present in the papule, which is developed in the scratch line. We report isolation of B. henselae from a swab specimen and the skin biopsy specimens sampled from the skin papule of 3 patients with CSD.
From January 2007 through February 2010, we tested 92 skin biopsy specimens from patients suspected of having CSD. DNA was extracted by using a QIAamp Tissue Kit (QIAGEN, Valencia, CA, USA) and was used as a template in a previously described real-time reverse transcription–PCR (RT-PCR) specific for a portion of the Bartonella 16S–23S intergenic spacer region and the PAP31 gene for detection of B. henselae (6). B. henselae was identified in 4 skin biopsy specimens (4.3%). For each patient, we received a skin biopsy specimen from the skin papule, a lymph node biopsy specimen, and paired serum samples. For 1 patient, we also received a swab from a skin papule. Immunoglobulin G and M titers were determined by using an immunofluorescent antibody assay (7).
Skin biopsy specimens and the swab were cultured in human embryonic lung fibroblasts by using the centrifugation shell-vial technique (3.7 mL; Sterilin Ltd., Felthan, UK); 12-mm round coverslips seeded with 1 mL of medium containing 50,000 cells and incubated in a 5% CO2 incubator at 37°C for 3 days were used to obtain a confluent monolayer (8). Cultures were surveyed for 4 weeks and detection of bacteria growth was assessed every 7 days on coverslips directly inside the shell vial by using Gimenez and immunofluorescence staining. We obtained a positive culture from 3 patients, and detailed histories are described below (Table).
Patient 1 was a 38-year-old man who had fever (40°C) and asthenia. The patient was a cat owner who had been scratched 8 days before onset of symptoms. Clinical signs were right axillary lymphadenitis and an inflammatory reddish skin lesion on the right hand with epitrochlear adenopathy, which appeared 2 days before he sought treatment. Abdominal ultrasound showed small hepatic abscesses. After the skin biopsy sample was obtained, doxycycline (200 mg/d) was given for 1 week. The patient fully recovered.
Patient 2 was a 17-year-old man with an inflamed red skin lesion on the right foot and epitrochlear adenopathy. The patient reported that he was scratched ≈1 week earlier by his cat and that the skin lesion appeared the day before he sought treatment. Right inguinal lymphadenitis was also identified during examination.
Patient 3 was a 20-year-old man had an inflammatory skin lesion on the left hand. He had a cat scratch 9 days before; the skin papule appeared 1 day before he sought treatment. Left axilliary lymphadenitis was identified during the examination and abdominal ultrasound showed hepatomegaly.
Skin biopsy specimens and lymph nodes from all patients were positive by real-time RT-PCR; patient 2 also had a positive swab specimen. Moreover, all patients had serum samples positive for B. henselae by immunofluorescent antibody assay. We detected gram-negative bacilli (Figure), which were identified as B. henselae by real-time RT-PCR (6), in the cultures of the skin biopsies and swab specimen. Patients 2 and 3 recovered without treatment.
We isolated B. henselae from skin biopsy specimens of 3 patients with CSD. Patients with CSD usually have gradual regional lymph node enlargement, accompanied by a papule, which develops in the scratch line after 3–10 days; the papule may persist for only a few days or as long as 2–3 weeks (9). Histopathologic appearance of the skin lesion is similar to lymph node changes, consisting of a diffuse inflammatory cell infiltrate associating numerous neutrophils and histiocytes mixed with scattered eosinophils and plasma cells (9). Other more unusual skin manifestations include morbilliform eruptions, urticaria, erythema nodosum, erythema multiforme, and erythema marginatum (9). B. henselae in the skin papule was first proposed by Wear et al., who reported that the primary inoculation site and the lymph nodes of patients with CSD contained the same small Gram-negative bacilli (10). Using immunohistochemical stain, Lin et al. found B. henselae in the cytoplasm of histiocytes within the granulomatous lesions in 9 lymph nodes and 1 skin biopsy specimen from patients with CSD (11). Avidor et al. identified B. henselae in inflammatory papules and pustules of 2 patients with CSD (12). Our group recently identified B. henselae in patients with scalp eschars and neck lymphadenopathy after tick bites (5). Moreover, Fournier et al. detected B. henselae in 2 skin biopsy specimens of a primary papule from patients in Australia clinically suspected of having CSD (2).
Swabs of lesions for the diagnosis and culture of B. henselae are not widely used. Fournier et al. found that swabs from 6 primary skin papules from patients clinically suspected of having CSD were positive for B. henselae; a positive culture was also obtained from 1 cutaneous swab (2). For rickettsial diseases, in 2006, the diagnosis of 1 case of scrub typhus was based on PCR results of the patient’s eschar (13). Wang et al. identified 3 cases of Queensland tick typhus caused by Rickettsia australis and 1 case of African tick bite fever caused by R. africae by the use of PCR in dry and sterile saline moistened swabs collected from the eschar margin (14). B. henselae is often isolated from cutaneous tumors in AIDS and immunocompromised patients with bacillary angiomatosis (15); however, all our patients were immunocompetent.
In conclusion, we found live B. henselae in the primary inoculation site after a cat scratch. An incubation period of 2–3 weeks was necessary to obtain B. henselae isolates from the skin lesion, therefore, cultures are not proposed for point-of-care diagnosis. To reduce the delay in diagnosis, real-time RT-PCR enables rapid detection and identification of CSD in skin biopsy specimens and swabs. Probably crucial for the isolation of B. henselae was the fact that the skin biopsy specimens and the swab were sampled early after appearance of the skin papule and that patients did not receive treatment. Two of 3 patients recovered without antimicrobial drug treatment, which leads us to believe that treatment with antimicrobial drugs is not necessary for immunocompetent patients. A cutaneous swab of the skin lesion in the early stage of CSD infection may replace the more painful skin or lymph node biopsies.
Dr Angelakis is a clinician and researcher at the Unité des Rickettsies in Marseille. His research interests are zoonotic pathogens.
- Resto-Ruiz S, Burgess A, Anderson BE. The role of the host immune response in pathogenesis of Bartonella henselae. DNA Cell Biol. 2003;22:431–40.
- Fournier PE, Robson J, Zeaiter Z, McDougall R, Byrne S, Raoult D. Improved culture from lymph nodes of patients with cat scratch disease and genotypic characterization of Bartonella henselae isolates in Australia. J Clin Microbiol. 2002;40:3620–4.
- Rolain JM, Lepidi H, Zanaret M, Triglia JM, Michel G, Thomas PA, Lymph node biopsy specimens and diagnosis of cat-scratch disease. Emerg Infect Dis. 2006;12:1338–44.
- Kunz S, Oberle K, Sander A, Bogdan C, Schleicher U. Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta. Am J Pathol. 2008;172:1005–18.
- Angelakis E, Pulcini C, Waton J, Imbert P, Socolovschi C, Edouard S, Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after tick bite. Clin Infect Dis. 2010;50:549–51.
- Angelakis E, Roux V, Raoult D, Rolain JM. Real-time PCR strategy and detection of bacterial agents of lymphadenitis. Eur J Clin Microbiol Infect Dis. 2009;28:1363–8.
- Maurin M, Rolain JM, Raoult D. Comparison of in-house and commercial slides for detection of immunoglobulins G and M by immunofluorescence against Bartonella henselae and Bartonella quintana. Clin Diagn Lab Immunol. 2002;9:1004–9.
- Gouriet F, Fenollar F, Patrice JY, Drancourt M, Raoult D. Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience. J Clin Microbiol. 2005;43:4993–5002.
- Chian CA, Arrese JE, Pierard GE. Skin manifestations of Bartonella infections. Int J Dermatol. 2002;41:461–6.
- Wear DJ, Margileth AM, Hadfield TL, Fischer GW, Schlagel CJ, King FM. Cat scratch disease: a bacterial infection. Science. 1983;221:1403–5.
- Lin YY, Hsiao CH, Hsu YH, Lee CC, Tsai HJ, Pan MJ. Immunohistochemical study of lymph nodes in patients with cat scratch disease. J Formos Med Assoc. 2006;105:911–7.
- Avidor B, Varon M, Marmor S, Lifschitz-Mercer B, Kletter Y, Ephros M, DNA amplification for the diagnosis of cat-scratch disease in small-quantity clinical specimens. Am J Clin Pathol. 2001;115:900–9.
- Lee SH, Kim DM, Cho YS, Yoon SH, Shim SK. Usefulness of eschar PCR for diagnosis of scrub typhus. J Clin Microbiol. 2006;44:1169–71.
- Wang JM, Hudson BJ, Watts MR, Karagiannis T, Fisher NJ, Anderson C, Diagnosis of Queensland tick typhus and African tick bite fever by PCR of lesion swabs. Emerg Infect Dis. 2009;15:963–5.
- Gasquet S, Maurin M, Brouqui P, Lepidi H, Raoult D. Bacillary angiomatosis in immunocompromised patients: a clinicopathological and microbiological study of seven cases and review of literature. AIDS. 1998;12:1793–803.
- Figure. Gimenez stain of Bartonella henselae obtained by the culture in human embryonic lung of the skin biopsy of a patient with cat scratch disease, France, 2010. Original magnification ×100.
- Table. Assessment and testing results for 3 patients with cat scratch disease who had skin biopsy specimens positive for Bartonella henselae, France, 2010
Please use the form below to submit correspondence to the authors or contact them at the following address:
Didier Raoult, Faculte de Medecine, Unite des Rickettsies, UMR6020, IFR 48, Centre National de Reference Centre Collaborateur OMS, 27 Blvd Jean Moulin, Marseille 13005, France
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 29, 2011
- Page last updated: August 29, 2011
- Page last reviewed: August 29, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)